Targeting regulatory T cells in anti‐PD‐1/PD‐L1 cancer immunotherapy
Authors:
Open Access
- 22 December 2021
- journal article
- review article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 95 (3) , e13129
Abstract
The programmed death (PD)‐1/PD‐ligand (PD‐L) pathway and regulatory T cells (Tregs) are essential for the maintenance of immune tolerance. Their activation in the tumour microenvironment contributes to the evasion of the transformed cells from the immune surveillance and the suppression of an antitumour immune response. Therefore, PD‐1/PD‐L1 and Tregs are important targets for cancer immunotherapy. Our review focuses on the current role of the PD‐1/PD‐L1 axis in Treg development and function in the tumour microenvironment. We also discuss combination therapy with PD‐1/PD‐L1 inhibitors and Treg‐modulating agents affecting the adenosinergic pathway, TGF‐β signalling, immune checkpoints and other approaches to downregulation of Tregs.Keywords
Funding Information
- Ministry of Science and Higher Education of the Russian Federation (project No. 0218‐2019‐0083)
This publication has 98 references indexed in Scilit:
- Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbsClinical Cancer Research, 2013
- Intratumor Hypoxia Promotes Immune Tolerance by Inducing Regulatory T Cells via TGF-β1 in Gastric CancerPLOS ONE, 2013
- Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancerInternational Journal of Cancer, 2012
- Induced and natural regulatory T cells in human cancerExpert Opinion on Biological Therapy, 2012
- Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivoProceedings of the National Academy of Sciences, 2012
- The PDL1-PD1 Axis Converts Human T H 1 Cells into Regulatory T CellsScience Translational Medicine, 2011
- Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humansBlood, 2011
- Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma PatientsClinical Cancer Research, 2010
- PD-L1 regulates the development, maintenance, and function of induced regulatory T cellsJournal of Experimental Medicine, 2009
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009